Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dexyane MeD + desonide represents a combination approach to eczema treatment. Dexyane MeD is a medical device designed to treat and limit recurrence of eczema lesions, particularly for very dry skin prone to atopic eczema, contact eczema, and chronic eczema on hands and eyelids. It can be used alone, in combination with, or as follow-up to medicinal treatments. Desonide is a low-potency topical corticosteroid that works by activating natural substances in the skin to reduce swelling, redness, and itching. It comes in various forms including cream, ointment, gel, foam, and lotion. The combination approach would typically involve using desonide for acute inflammation control and Dexyane MeD for ongoing skin barrier repair and maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dexyane MeD + desonide.